{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T02:48:55Z","timestamp":1788058135784,"version":"build-2784847793"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.vaccine.2024.126700","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T20:13:06Z","timestamp":1736280786000},"page":"126700","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["A universal live vaccine platform against multiple serotypes Streptococcus suis based on polyvalent antigen protein"],"prefix":"10.1016","volume":"47","author":[{"given":"Wenjing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-an","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shifeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huoying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.126700_bb0005","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/bs.ampbs.2020.12.002","article-title":"Streptococcus suis pathogenesis-A diverse array of virulence factors for a zoonotic lifestyle","volume":"78","author":"Tram","year":"2021","journal-title":"Adv Microb Physiol"},{"key":"10.1016\/j.vaccine.2024.126700_bb0010","doi-asserted-by":"crossref","DOI":"10.1038\/emi.2014.45","article-title":"Streptococcus suis, an important pig pathogen and emerging zoonotic agent-an update on the worldwide distribution based on serotyping and sequence typing","volume":"3","author":"Goyette-Desjardins","year":"2014","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.vaccine.2024.126700_bb0015","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S1473-3099(13)70318-9","article-title":"Antibiotic resistance-the need for global solutions","volume":"13","author":"Laxminarayan","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126700_bb0020","first-page":"53","article-title":"How Streptococcus suis escapes antibiotic treatments","author":"C U, C G, L F, J T, J A.","year":"2022","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2024.126700_bb0025","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13567-017-0494-6","article-title":"Salmonella enterica serovar Choleraesuis vector delivering SaoA antigen confers protection against Streptococcus suis serotypes 2 and 7 in mice and pigs","volume":"48","author":"Li","year":"2017","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2024.126700_bb0030","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3390\/vaccines10030472","article-title":"Immunogenicity and safety of childhood combination vaccines: A systematic review and meta-analysis","volume":"10","author":"Liu","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2024.126700_bb0035","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3390\/vaccines10030473","article-title":"Comparative reverse vaccinology of Piscirickettsia salmonis, Aeromonas salmonicida, Yersinia ruckeri, vibrio anguillarum and Moritella viscosa, frequent pathogens of Atlantic Salmon and Lumpfish aquaculture","volume":"10","author":"Chukwu-Osazuwa","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2024.126700_bb0040","doi-asserted-by":"crossref","first-page":"e00455","DOI":"10.1128\/mSphere.00455-19","article-title":"Multilaboratory comparison of pneumococcal multiplex immunoassays used in immunosurveillance of Streptococcus pneumoniae across Europe","volume":"4","author":"Meek","year":"2019","journal-title":"mSphere"},{"key":"10.1016\/j.vaccine.2024.126700_bb0045","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00316-23","article-title":"A broadly immunogenic polyvalent Shigella multiepitope fusion antigen protein protects against Shigella sonnei and Shigella flexneri lethal pulmonary challenges in mice","volume":"91","author":"Li","year":"2023","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2024.126700_bb0050","doi-asserted-by":"crossref","first-page":"6195","DOI":"10.1038\/s41467-023-41661-4","article-title":"Nanoparticle display of prefusion coronavirus spike elicits S1-focused cross-reactive antibody response against diverse coronavirus subgenera","volume":"14","author":"Hutchinson","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2024.126700_bb0055","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1111\/tbed.12067","article-title":"Evaluation on a Streptococcus suis vaccine using recombinant sao-l protein manufactured by bioreactors as the antigen in pigs","volume":"61","author":"Hsueh","year":"2014","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2024.126700_bb0060","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1086\/644602","article-title":"Streptococcus suis enolase functions as a protective antigen displayed on the bacterial cell surface","volume":"200","author":"Feng","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126700_bb0065","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.vetmic.2008.02.025","article-title":"Cloning, expression and characterization of a cell wall surface protein, 6-phosphogluconate-dehydrogenase, of Streptococcus suis serotype 2","volume":"130","author":"Tan","year":"2008","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2024.126700_bb0070","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1016\/j.vaccine.2009.06.074","article-title":"Identification of a surface protective antigen, HP0197 of Streptococcus suis serotype 2","volume":"27","author":"Zhang","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126700_bb0075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00284-008-9258-x","article-title":"Identification and experimental verification of protective antigens against Streptococcus suis serotype 2 based on genome sequence analysis","volume":"58","author":"Liu","year":"2009","journal-title":"Curr Microbiol"},{"key":"10.1016\/j.vaccine.2024.126700_bb0080","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.micres.2013.09.007","article-title":"Prevalent distribution and conservation of Streptococcus suis Lmb protein and its protective capacity against the Chinese highly virulent strain infection","volume":"169","author":"Zhang","year":"2014","journal-title":"Microbiol Res"},{"key":"10.1016\/j.vaccine.2024.126700_bb0085","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1080\/21505594.2015.1056971","article-title":"The type II histidine triad protein HtpsC is a novel adhesion with the involvement of Streptococcus suis virulence","volume":"6","author":"Li","year":"2015","journal-title":"Virulence"},{"key":"10.1016\/j.vaccine.2024.126700_bb0090","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1128\/CVI.00046-07","article-title":"Immunization with recombinant Sao protein confers protection against Streptococcus suis infection","volume":"14","author":"Li","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2024.126700_bb0095","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12917-016-0937-8","article-title":"Immunization with Streptococcus suis bacterin plus recombinant Sao protein in sows conveys passive immunity to their piglets","volume":"13","author":"Hsueh","year":"2017","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.vaccine.2024.126700_bb0100","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1016\/j.vaccine.2020.08.062","article-title":"Live attenuated Salmonella enterica serovar Choleraesuis vector delivering a conserved surface protein enolase induces high and broad protection against Streptococcus suis serotypes 2, 7, and 9 in mice","volume":"38","author":"Li","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126700_bb0105","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1574-6968.2009.01551.x","article-title":"Immunization with SsEno fails to protect mice against challenge with Streptococcus suis serotype 2","volume":"294","author":"Esgleas","year":"2009","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.vaccine.2024.126700_bb0110","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s00239-004-2630-y","article-title":"Functional constraints of 6-phosphogluconate dehydrogenase (6-PGD) based on sequence and structural information","volume":"59","author":"Goulielmos","year":"2004","journal-title":"J Mol Evol"},{"key":"10.1016\/j.vaccine.2024.126700_bb0115","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1574-6968.2009.01617.x","article-title":"Vaccination with Streptococcus suis serotype 2 recombinant 6PGD protein provides protection against S. Suis infection in swine","volume":"296","author":"Tan","year":"2009","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.vaccine.2024.126700_bb0120","doi-asserted-by":"crossref","first-page":"4858","DOI":"10.1016\/j.vaccine.2015.07.063","article-title":"Live attenuated Salmonella enterica serovar Choleraesuis vaccine vector displaying regulated delayed attenuation and regulated delayed antigen synthesis to confer protection against Streptococcus suis in mice","volume":"33","author":"Ji","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126700_bb0125","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1073\/pnas.96.4.1615","article-title":"Immunogenicity and in vitro protective efficacy of a recombinant multistage plasmodium falciparum candidate vaccine","volume":"96","author":"Shi","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2024.126700_bb0130","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ebiom.2017.07.005","article-title":"A multistage subunit vaccine effectively protects mice against primary progressive tuberculosis","volume":"22","author":"Ma","year":"2017","journal-title":"Latency and Reactivation EBioMedicine"},{"key":"10.1016\/j.vaccine.2024.126700_bb0135","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3390\/vaccines11051004","article-title":"Bovine Herpesvirus-4 based vaccine provides protective immunity against Streptococcus suis disease in a rabbit model","volume":"11","author":"Dong","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2024.126700_bb0140","doi-asserted-by":"crossref","DOI":"10.1128\/aem.02047-22","article-title":"Engineered bacterial outer membrane vesicles with Lipidated heterologous antigen as an adjuvant-free vaccine platform for Streptococcus suis","volume":"89","author":"Li","year":"2023","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.vaccine.2024.126700_bb0145","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1128\/IAI.70.4.1739-1749.2002","article-title":"Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar typhimurium vaccine","volume":"70","author":"Kang","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2024.126700_bb0150","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1128\/IAI.01623-07","article-title":"Analysis of type II secretion of recombinant pneumococcal PspA and PspC in a Salmonella enterica serovar typhimurium vaccine with regulated delayed antigen synthesis","volume":"76","author":"Xin","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2024.126700_bb0155","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3390\/vaccines12030249","article-title":"Construction and evaluation of an efficient live attenuated Salmonella Choleraesuis vaccine and its ability as a vaccine carrier to deliver heterologous antigens","volume":"12","author":"Bian","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2024.126700_bb0160","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.3390\/molecules27072375","article-title":"Potential immunogenic activity of computationally designed mRNA- and peptide-based prophylactic vaccines against MERS, SARS-CoV, and SARS-CoV-2: A reverse vaccinology approach","volume":"27","author":"Khan","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.vaccine.2024.126700_bb0165","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1016\/j.vaccine.2013.12.026","article-title":"The delicate balance in genetically engineering live vaccines","volume":"32","author":"Galen","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126700_bb0170","article-title":"A bacterial mRNA-lysis-mediated cargo release vaccine system for regulated cytosolic surveillance and optimized antigen delivery","volume":"10","author":"Li","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.vaccine.2024.126700_bb0175","first-page":"48","article-title":"Subunit vaccine targeting phosphate ABC transporter ATP-binding protein, PstB, provides cross-protection against Streptococcus suis serotype 2, 7, and 9 in mice","volume":"10","author":"Yan","year":"2023","journal-title":"Vet Sci"},{"key":"10.1016\/j.vaccine.2024.126700_bb0180","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3390\/vaccines9020184","article-title":"TLR4 agonist combined with trivalent protein JointS of Streptococcus suis provides immunological protection in animals","volume":"9","author":"Wang","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2024.126700_bb0185","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1128\/IAI.00445-10","article-title":"Comparison of a regulated delayed antigen synthesis system with in vivo-inducible promoters for antigen delivery by live attenuated Salmonella vaccines","volume":"79","author":"Wang","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2024.126700_bb0190","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1016\/j.vaccine.2015.07.003","article-title":"Efficacy and immunogenicity of high-dose influenza vaccine in older adults by age, comorbidities, and frailty","volume":"33","author":"DiazGranados","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126700_bb0195","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2249.2006.03019.x","article-title":"T cell-mediated oral tolerance is intact in germ-free mice","volume":"143","author":"Walton","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2024.126700_bb0200","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3390\/vaccines12050544","article-title":"Immunogenicity and protective capacity of sugar ABC transporter substrate-binding protein against Streptococcus suis serotype 2, 7 and 9 infection in mice","volume":"12","author":"Yan","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2024.126700_bb0205","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41541-024-01015-7","article-title":"A multi-epitope subunit vaccine providing broad cross-protection against diverse serotypes of Streptococcus suis","volume":"9","author":"Liu","year":"2024","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2024.126700_bb0210","first-page":"48","article-title":"Subunit vaccine targeting phosphate ABC transporter ATP-binding protein, PstB, provides cross-protection against Streptococcus suis serotype 2, 7, and 9 in mice","volume":"10","author":"Yan","year":"2023","journal-title":"Vet Sci"},{"key":"10.1016\/j.vaccine.2024.126700_bb0215","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1111\/tbed.12067","article-title":"Evaluation on a Streptococcus suis vaccine using recombinant sao-l protein manufactured by bioreactors as the antigen in pigs","volume":"61","author":"Hsueh","year":"2014","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2024.126700_bb0220","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.antiviral.2014.07.008","article-title":"VP2, VP7, and NS1 proteins of bluetongue virus targeted in avian reovirus muNS-mi microspheres elicit a protective immune response in IFNAR(\u2212\/\u2212) mice","volume":"110","author":"Mar\u00edn-L\u00f3pez","year":"2014","journal-title":"Antivir Res"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2024.126700_bb0225","doi-asserted-by":"crossref","first-page":"S414","DOI":"10.1093\/infdis\/jiv251","article-title":"Preclinical development of inactivated rabies virus-based polyvalent vaccine against rabies and filoviruses","volume":"212","author":"Willet","year":"2015","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24013823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24013823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T18:36:18Z","timestamp":1740335778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24013823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":45,"alternative-id":["S0264410X24013823"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126700","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A universal live vaccine platform against multiple serotypes Streptococcus suis based on polyvalent antigen protein","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126700","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126700"}}